November news roundup

Consensus statement on Rh pregnancy testing

Rhesus (Rh) immunoglobulin should be given only after 12 weeks gestation for spontaneous abortion, or for medication or uterine aspiration abortion, according to a new consensus statement from the Society of Family Planning (SFP).

Prenatal care limited among immigrant groups

In a recent study, immigrant women were less likely to receive access to timely prenatal care than women born in the United States.

Pfizer announces topline data for its bivalent RSV vaccine candidate

Pfizer announced that its bivalent respiratory syncytial virus vaccine—when given to women during pregnancy—has shown effective in protecting infants from reducing severe symptoms during their first 6 months of birth.

Hospitals, health systems, and providers having one of the most difficult financial years on record

Declining volume and revenue with increasing expenses mean many systems are ending the year in the red.

Endometrial ablation in the office setting

Breaking down barriers through patient selection, new devices, and the latest techniques.

EMIGS: A new standard of care

In an exclusive interview, Nash Moawad, MD, MS, FACOG, FACS, discussed the recent implementation of the Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program, which helps physicians provide the best care and ensure optimal safety for their patients.

CDC updates opioid prescribing guidelines

Revisions to 2016 document focus on provider flexibility and unique circumstances of every prescribing decision.

November is for diabetes awareness

November is Diabetes Awareness Month.

Diagnosing and treating the adolescent with irregular menstruation

November 08, 2022

ByLois Levine

At the 2022 AAP National Conference & Exhibition, a professor from the Baylor College of Medicine discusses how to develop an approach to investigate menstrual disturbances for adolescent patients and understand treatment options.

Highlights from the 25th Annual Premier Women’s Healthcare Conference

Houston, Texas, was buzzing with the latest updates in women’s health at the 25th Annual Nurse Practitioners in Women’s Health Premier Women’s Healthcare Conference held from September 29 to October 2, 2022.

Chemical hair straightening may increase uterine cancer risk

A new NIH study found women who used chemical hair straightening products to be at a higher risk for uterine cancer than women who didn’t use these products.

FDA approves IUD to prevent pregnancy for up to 8 years

The Food and Drug Administration (FDA) has approved Medicine360’s supplemental new drug application to extend the use of its levongestrel-releasing intrauterine system 52mg (LILETTA) to prevent pregnancy for up to 8 years.

Iranian hackers emerge as cyberthreat to health care computer networks

‘Charming Kitten’ believed to be a front for Islamic Revolutionary Guard Corps, according to HHS’ cybersecurity agency.

Dare Bioscience announces grant to develop vaginal thermosetting gel for delivery of live biotherapeutics

Daré Bioscience announced yesterday that it has received a grant from the Bill & Melinda Gates Foundation of $584,986 to support its efforts related to the development of a vaginal thermosetting gel formulation for the delivery of live biotherapeutics that can be reconstituted at the point of care.

Amazon Clinic to offer online primary care services in 32 states

Telehealth store doesn’t accept insurance yet, but Amazon Pharmacy will deliver prescriptions.

FDA grants accelerated approval to mirvetuximab soravtansine-gynx for ovarian cancer

This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.

Five minutes of a doctor’s time could cost patients $50

Cleveland Clinic begins charging for doctors’ time spent responding to some electronic messages.